Skip to content
Recall Observatory FDA recall evidence

Drug product

Theophylline (Anhydrous) Extended-Release Tablets, 600 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited. Colvale-Bardez, Goa - 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430. NDC: 68462-356-01

D-0452-2025

May 15, 2025

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 96867
Status
Ongoing
Classification
Class II
Quantity
8,520 100-count bottles
Official record key
drug-enforcement:D-0452-2025

Official wording

Reason: OOS results reported for the Dissolution (by UV) test.

Code information: Lots: 19234121, 19234148, Exp Sep-30-25; Lots 19242881, 19242899, Exp Jun-30-26

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    OOS results reported for the Dissolution (by UV) test.